SGO on the GO
ERAS Guidelines: Same Day Discharge (SDD)
In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS).
Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activity.
Postoperative hospitalization is typically shorter after minimally invasive (MIS) hysterectomy, and many patients may even be candidates for discharge on the day of surgery, so-called same-day discharge (SDD).
2023-2024 SGO ERAS Subcommittee Members and Speakers:
Lee-may Chen, MD; Subcommittee Lead and Moderator
Nawar Latif, MD, MPH, MSCE
Clarissa Polen-De, MD
Michael Shu, MD
Collin Sitler, DO
Brenna Swift, MD, MASc, MSc, FRCSC
Diogo Torres, MD
In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS).
Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activity.
Postoperative hospitalization is typically shorter after minimally invasive (MIS) hysterectomy, and many patients may even be candidates for discharge on the day of surgery, so-called same-day discharge (SDD).
2023-2024 SGO ERAS Subcommittee Members and Speakers:
Lee-may Chen, MD; Subcommittee Lead and Moderator
Nawar Latif, MD, MPH, MSCE
Clarissa Polen-De, MD
Michael Shu, MD
Collin Sitler, DO
Brenna Swift, MD, MASc, MSc, FRCSC
Diogo Torres, MD